🇺🇸 FDA
Patent

US 8956616

Constructs binding to phosphatidylserine and their use in disease treatment

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 8956616 (Constructs binding to phosphatidylserine and their use in disease treatment) held by The Board of Regents of the University of Texas System expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K2039/505, A61K38/00, A61K38/17, A61K38/1709